Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;27(2):258-263.
doi: 10.1016/j.cmi.2020.09.052. Epub 2020 Oct 5.

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Claudia Carvalho-Schneider  1 , Emeline Laurent  2 , Adrien Lemaignen  3 , Emilie Beaufils  4 , Céline Bourbao-Tournois  5 , Saïd Laribi  6 , Thomas Flament  7 , Nicole Ferreira-Maldent  8 , Franck Bruyère  9 , Karl Stefic  10 , Catherine Gaudy-Graffin  10 , Leslie Grammatico-Guillon  11 , Louis Bernard  3
Affiliations

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Claudia Carvalho-Schneider et al. Clin Microbiol Infect. 2021 Feb.

Abstract

Objectives: To describe the clinical evolution and predictors of symptom persistence during 2 months' follow-up in adults with noncritical coronavirus disease 2019 (COVID-19).

Methods: We performed descriptive clinical follow-up (day (D) 7, D30 and D60) of 150 patients with noncritical COVID-19 confirmed by real-time reverse transcriptase PCR at Tours University Hospital from 17 March to 3 June 2020, including demographic, clinical and laboratory data collected from the electronic medical records and by phone call. Persisting symptoms were defined by the presence at D30 or D60 of at least one of the following: weight loss ≥5%, severe dyspnoea or asthenia, chest pain, palpitations, anosmia/ageusia, headache, cutaneous signs, arthralgia, myalgia, digestive disorders, fever or sick leave.

Results: At D30, 68% (103/150) of patients had at least one symptom; and at D60, 66% (86/130) had symptoms, mainly anosmia/ageusia: 59% (89/150) at symptom onset, 28% (40/150) at D30 and 23% (29/130) at D60. Dyspnoea concerned 36.7% (55/150) patients at D30 and 30% (39/130) at D60. Half of the patients (74/150) at D30 and 40% (52/130) at D60 reported asthenia. Persistent symptoms at D60 were significantly associated with age 40 to 60 years old, hospital admission and abnormal auscultation at symptom onset. At D30, severe COVID-19 and/or dyspnoea at symptom onset were additional factors associated with persistent symptoms.

Conclusions: Up to 2 months after symptom onset, two thirds of adults with noncritical COVID-19 had complaints, mainly anosmia/ageusia, dyspnoea or asthenia. A prolonged medical follow-up of patients with COVID-19 seems essential, whatever the initial clinical presentation.

Keywords: Description; Follow-up; Mild COVID-19; Moderate COVID-19; Noncritical COVID-19; Outcomes; Persisting symptoms.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of study design. OCEC, outpatient clinical evaluation centre.
Fig. 2
Fig. 2
Predictors of persistent coronavirus disease 2019 (COVID-19) symptoms.
See this image and copyright information in PMC

References

    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. - PMC - PubMed
    1. Spinato G., Fabbris C., Polesel J., Cazzador D., Borsetto D., Hopkins C. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020 - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Cecconi M., Piovani D., Brunetta E., Aghemo A., Greco M., Ciccarelli M. Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy. J Clin Med. 2020;9:1548. - PMC - PubMed

MeSH terms